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Abstract: A 38-year-old woman presented with 2 days history of left-flank pain. She had 
similar episodes of abdominal pain as well as chest pain several times, but symptoms disappeared 
spontaneously. Each time she developed pain, there was no fever. After ruling out common 
causes of recurrent abdominal pain, familial Mediterranean fever (FMF) was considered as 
a potential diagnosis. Genetic tests revealed multiple heterozygote mutations, which may be 
associated with FMF. Patients with Mediterranean fever mutations may present with atypical 
presentations without fever, like in this case. Astute clinical suspicion is required to make an 
accurate diagnosis.
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Introduction
Abdominal pain in premenopausal women is often a diagnostic challenge. We 
describe a case of 38-year-old woman who presented with recurrent abdominal pain. 
A   conventional work-up failed to reveal a diagnosis. A detailed history suggested 
recurrent serositis syndrome. Although the patient denied fever, a diagnosis of FMF 
was considered. We discuss the rationale for the diagnosis and interpretation of 
genetic tests.
Case report
A 38-year-old woman presented reporting 2 days of left-sided abdominal pain. The 
pain was intermittent in nature. She denied any fever, gastrointestinal symptoms, 
respiratory symptoms and genitourinary symptoms. Her last menstrual period was 
a few weeks ago and she denied pregnancy. Eight years prior to the current pre-
sentation, she developed left-side chest pain worsened by deep inspiration. A chest 
radiograph reportedly revealed atelectasis and she was diagnosed with “pleuritis with 
middle lobe lingual syndrome”. She did not recall whether she had a fever since then. 
Three years (44 months to be precise) prior to the current presentation, she developed 
acute onset left-flank pain without fever. She visited a urology clinic but the urinalysis 
was   normal. An urologist who saw the patient considered her condition was unlikely to 
be urolithiasis but was not able to find an alternative explanation. Her pain disappeared 
without specific treatment several days later. Thirty-five months prior to the current 
presentation, she developed left-side chest and back pain without fever. Blood tests 
showed a white blood cell (WBC) count of 7,000/mm3 and C-reactive protein (CRP) 
of 1.69 mg/dL. There was an elevated liver function test (aspartate aminotransferase 
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[AST] 48 U/L, alanine aminotransferase [ALT] 66 U/L). 
A physician caring for her diagnosed it as pleuritis and an 
oral antibiotic was prescribed. At a follow-up visit 3 days 
later, the patient became asymptomatic and laboratory 
abnormalities were all normalized. Twenty-six months prior 
to the current presentation, she developed another left-side 
chest pain without fever. A laboratory exam revealed WBC 
7600/mm3 and CRP was ,0.24 mg/dL. She was again diag-
nosed with pleuritis, and symptoms improved several days 
later (treatment detail unknown). Twenty-five months prior 
to the current presentation, she developed another abdominal 
pain. Pain was associated with her position and movement. 
WBC was 8600/mm3, with neutrophil 67% (4% band form), 
lymphocyte 27%, CRP 1.32 mg/dL, and erythrocyte sedimen-
tation rate (ESR) 36 mm/hour. The abdominal ultrasound was 
normal and a computed tomography scan without contrast 
of abdomen revealed incidental findings of spina bifida at 
sacrum and fatty liver but no abnormality at urinary tract or 
elsewhere. She had had no episode of pain since then until 
this current presentation.
Her past medical history was significant only for 
  childhood inguinal hernia, which was repaired surgically, 
and freckles, which were treated with topical agents. She 
denied allergy to medications, took no alcohol or illicit 
drugs, and denied tobacco smoking. She became pregnant 
twice and was the mother of 12- and 14-year-old children. 
There was no significant family history. She only took over-
  the-counter vitamins.
Upon presentation, the patient appeared well but 
suddenly started to suffer abdominal pain during the 
interview. She was not able to hold herself upright and 
had to lie down on a bed. On physical examination, she 
appeared ill. Her blood pressure was 125/76 mmHg, 
pulse rate 84/minute, respiratory rate 22/minute, and body 
temperature taken at axilla was 36.8°C. Her pain worsened 
upon deep inspiration. However, her physical examination 
was otherwise unremarkable, and there was no tenderness 
on her abdomen or on her back. Laboratory tests showed 
a CRP of 1.45 mg/dL (reference range , 0.24 mg/dL) and 
an ESR of 25 mm at 1 hour. The WBC differential was 
neutrophil 65.0% (5% band form), lymphocyte 22.0%, 
monocyte 13.0%, and eosinophil 0%. Due to a technical 
error, CBC was not performed, but later in the day it 
turned out to be normal. Electrolytes, liver function tests, 
and kidney function tests were all normal. Urinalysis 
was negative for protein and sugar, but there was 10–19 
RBC/HPF, 30–49 WBC/HPF, with trace bacteria. Serum 
thyroid-stimulating hormone (TSH) level was normal.
Her cause of abdominal pain was judged to be serositis, 
based on history and physical examination. After resting, 
her pain gradually improved and she was sent home with 
prescription of non-steroidal anti-inflammatory medicine 
as needed. On the follow-up visit a week later, she was 
completely asymptomatic. Rheumatoid factor, anti-nuclear 
antibody (ANA), complement level, C3, C4 level, and 
serum ferritin level measured at the first visit all turned out 
normal. Urinary lead and porphobilinogen were negative. 
Given the recurrent nature of multiorgan serositis, FMF was 
considered as a diagnosis despite the lack of fever. A genetic 
blood test was performed at the Department of Pediatrics, 
Graduate School of Medical Science and School of Medicine, 
Kanazawa University, and it revealed MEFV mutations at 
exon 3 (P369S and R408Q) and intron 8 (IVS8+8 C-T). 
The symptom has not recurred since this interview. After 
a discussion with the patient, prophylactic colchicine was 







Current presentation: Left-flank pain
Abdominal pain
Left-side chest pain
Left-side chest pain, back pain
and abnormal liver function
Left-flank pain. Urolithiasis?
Left-side chest pain with pleuritis?
Figure 1 Patient’s history of recurrent pain, prior to current presentation (PTCP).
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Discussion
Abdominal pain in premenopausal women can be a diagnostic 
challenge. Its cause may range from gastrointestinal, 
hepatobiliary, or urological to obstetric and gynecological. 
Occasionally, some diseases cause abdominal pain without 
findings on imaging studies, such as diabetic ketoacidosis, 
acute intermittent porphyria, lead poisoning, or conversion 
disorder. However, detailed history taking and physical 
examination often lead to accurate diagnosis. Moreover, 
the list of differential diagnoses of left-side abdominal 
pain, as in our case, is not long, compared to right-side 
abdominal pain.
FMF is an autosomal recessive, inherited periodic inflam-
matory syndrome, characterized by self-limited recurrent 
attacks of fever with serositis such as peritonitis, pleuritis and 
arthritis.1 It is known to occur mainly among Mediterranean 
and Middle Eastern populations such as non-Ashkenazi Jews, 
Arabs, Turks, and Armenians. Despite its name, FMF is now 
shown to occur worldwide. In Japan, more than 90 cases of 
FMF were reported.2–4 Its onset is usually early but onset 
over 50 years old has been reported.5 High fever is   present 
in more than 90% of cases with FMF,6 and fever was present 
in 98.8% of cases in a Japanese study.3 However, this may 
be due to underdiagnoses and underreporting of afebrile 
patients. In fact, the current diagnostic criteria do not neces-
sarily require fever for the diagnosis.1 This patient fulfilled 
only one minor criterion on the simplified version of the 
criteria, which is now widely used. However she fulfilled 
two minor and five supportive criteria of the more detailed 
version; ie, incomplete attacks of abdomen and chest (minor 
criteria), and severe attacks requiring bed rest, spontaneous 
remission, symptom-free interval, transient inflammatory 
response, and episodic hematuria (supportive criteria), for 
which the specificity of the diagnosis is 99%.1
Patients with FMF at late onset tend to have a less severe 
form, and this might in part explain her lack of fever. In fact, 
the Tel Hashomer Severity Score of the patient was only1,7 
which includes age in the scoring, suggesting she had a 
milder form of FMF.
FMF is caused by mutations in the Mediterranean fever 
gene (MEFV) on chromosome 16p13.3, which encodes 
protein named pyrin. Pyrin regulates production of IL-1β 
and activation of NF-κB. Lack of normal pyrin activity in 
FMF is considered to be the cause of excess cytokines and 
subsequent inflammatory attack.8
Diagnosis of FMF is usually made clinically. Genetic 
tests are not necessarily mandated, and the results may be 
normal in patients with FMF. Likewise, a family history may 
not be detected, as in our case. MEFV mutations   commonly 
seen in Japan are different from those of Mediterranean 
people, where M694V is most common. Typical mutations 
in Japanese patients are E148Q on exon 2, and M694I on 
exon 10.3,8 Our patient did not have either, and it may partly 
explain the milder form of symptoms. A combination of 
P369S and R408Q, which was detected in our case, was found 
in three Japanese cases, but there was only one case without 
E148Q.3 P369S and R408Q can be found even in healthy 
Japanese subjects. In one study, 3.9% and 3.3% of healthy 
Japanese had P369S and R408Q mutations, respectively.9 
According to The Registry of Hereditary Auto-Inflammatory 
Disorders Mutations database (http://fmf.igh.cnrs.fr/ISSAID/
infevers/), the combination of P369S and R408Q was first 
detected in an Armenian patient with FMF in 2007. Also, 
IVS8+8 C-T was detected together with L110P, E148Q, 
P369S, R408Q, and R501R in a   Vietnamese patient. However, 
a diagnosis of FMF was clinically not clear in the latter. The 
precise role of these mutations is not known, and they are 
seen in cases ranging from full-blown FMF to completely 
asymptomatic persons.10 In addition, these genetic abnormali-
ties may be related to inflammatory diseases other than FMF. 
For example, Japanese patients with rheumatoid arthritis 
are known to have a higher frequency of MEFV mutations.9 
Also, there is a case report of colchicine-responsive chronic 
recurrent multifocal osteomyelitis (CRMO) in a 14-year-old 
Japanese female with these mutations.11 These mutations 
were also seen in higher frequency in patients with systemic 
onset juvenile idiopathic arthritis (SoJIA)12 and Behçet’s 
disease.13–17 Further accumulation of clinical data on these 
mutations will help our understanding of the roles of these 
mutations.
In conclusion, we saw a case of recurrent serositis 
consisting with FMF despite the lack of fever. There were 
multiple MEFV gene mutations, and these may be related 
to the symptoms. Astute clinical suspicion is important 
in diagnosing FMF without fever. Further studies will be 
needed to delineate the precise nature of FMF in Japanese 
people.
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